Literature DB >> 24599979

Characterization of hepatitis delta virus in sub-Saharan Africa.

Iris E Andernach1, Lukas V Leiss, Zekiba S Tarnagda, Marc C Tahita, Jesse A Otegbayo, Joseph C Forbi, Sunday Omilabu, Ionela Gouandjika-Vasilache, Narcisse P Komas, Okwen P Mbah, Claude P Muller.   

Abstract

Hepatitis D virus (HDV) is a satellite of hepatitis B virus (HBV), and infection with this virus aggravates acute and chronic liver disease. While HBV seroprevalence is very high across sub-Saharan Africa, much less is known about HDV in the region. In this study, almost 2,300 blood serum samples from Burkina Faso (n=1,131), Nigeria (n=974), Chad (n=50), and the Central African Republic (n = 118) were screened for HBV and HDV. Among 743 HBsAg-positive serum samples, 74 were positive for HDV antibodies and/or HDV RNA, with considerable differences in prevalence, ranging from <2% (pregnant women from Burkina Faso) to 50% (liver patients from Central African Republic). HDV seems to be much more common in chronic liver disease patients in the Central African Republic (CAR) than in similar cohorts in Nigeria. In a large nested mother-child cohort in Burkina Faso, the prevalence of HDV antibodies was 10 times higher in the children than in their mothers, despite similar HBsAg prevalences, excluding vertical transmission as an important route of infection. The genotyping of 16 full-length and 8 partial HDV strains revealed clade 1 (17/24) in three of the four countries, while clades 5 (5/24) and 6 (2/24) were, at least in this study, confined to Central Nigeria. On the amino acid level, almost all our clade 1 strains exhibited a serine at position 202 in the hepatitis D antigen, supporting the hypothesis of an ancient African HDV-1 subgroup. Further studies are required to understand the public health significance of the highly varied HDV prevalences in different cohorts and countries in sub-Saharan Africa.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24599979      PMCID: PMC3993620          DOI: 10.1128/JCM.02297-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Hepatitis D infection in Nigeria.

Authors:  C A Onyekwere; R A Audu; F Duro-Emmanuel; F A Ige
Journal:  Indian J Gastroenterol       Date:  2012-01

2.  High prevalence and predominance of hepatitis delta virus genotype 1 infection in Cameroon.

Authors:  Yacouba Foupouapouognigni; Dominique Noah Noah; Michèle Tagni Sartre; Richard Njouom
Journal:  J Clin Microbiol       Date:  2011-01-05       Impact factor: 5.948

3.  Phylogenetic analysis of hepatitis D viruses indicating a new genotype I subgroup among African isolates.

Authors:  Y Y Zhang; E Tsega; B G Hansson
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

4.  Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis.

Authors:  J C Wu; T Y Chiang; I J Sheen
Journal:  J Gen Virol       Date:  1998-05       Impact factor: 3.891

5.  Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study.

Authors:  Françoise Lunel-Fabiani; Wael Mansour; Abdellahi Ould Amar; Mohamed Aye; Frédéric Le Gal; F-Zahra Fall Malick; Lô Baïdy; Ségolène Brichler; Pascal Veillon; Alexandra Ducancelle; Emmanuel Gordien; Michel Rosenheim
Journal:  J Infect       Date:  2013-06-22       Impact factor: 6.072

6.  Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations.

Authors:  Christophe M Olinger; Véronique Venard; Mounjohou Njayou; Akeeb O Bola Oyefolu; Ibrahim Maïga; Alain J Kemp; Sunday A Omilabu; Alain le Faou; Claude P Muller
Journal:  J Gen Virol       Date:  2006-05       Impact factor: 3.891

7.  Evolution and diversity of the human hepatitis d virus genome.

Authors:  Chi-Ruei Huang; Szecheng J Lo
Journal:  Adv Bioinformatics       Date:  2010-02-24

8.  The prevalence of hepatitis B virus markers in a cohort of students in Bangui, Central African Republic.

Authors:  Narcisse P Komas; Souleyman Baï-Sepou; Alexandre Manirakiza; Josiane Léal; Aubin Béré; Alain Le Faou
Journal:  BMC Infect Dis       Date:  2010-07-29       Impact factor: 3.090

9.  A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J.

Authors:  Kanako Tatematsu; Yasuhito Tanaka; Fuat Kurbanov; Fuminaka Sugauchi; Shuhei Mano; Tatsuji Maeshiro; Tomokuni Nakayoshi; Moriaki Wakuta; Yuzo Miyakawa; Masashi Mizokami
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

10.  Eighth major clade for hepatitis delta virus.

Authors:  Frédéric Le Gal; Elyanne Gault; Marie-Pierre Ripault; Jeanne Serpaggi; Jean-Claude Trinchet; Emmanuel Gordien; Paul Dény
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883

View more
  22 in total

1.  A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians.

Authors:  Xiaohua Chen; Odgerel Oidovsambuu; Ping Liu; Rosslyn Grosely; Menashe Elazar; Virginia D Winn; Benjamin Fram; Zhang Boa; Hongjie Dai; Bekhbold Dashtseren; Dahgwahdorj Yagaanbuyant; Zulkhuu Genden; Naranbaatar Dashdorj; Andreas Bungert; Naranjargal Dashdorj; Jeffrey S Glenn
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

2.  Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda.

Authors:  Elizabeth Katwesigye; Emmanuel Seremba; Fred Semitala; Ponsiano Ocama
Journal:  Afr Health Sci       Date:  2016-12       Impact factor: 0.927

Review 3.  Pathogenesis of and New Therapies for Hepatitis D.

Authors:  Christopher Koh; Theo Heller; Jeffrey S Glenn
Journal:  Gastroenterology       Date:  2018-10-18       Impact factor: 22.682

4.  Prevalence and Characteristics of Hepatitis Delta Virus Infection in a Tertiary Hospital Setting in Cameroon.

Authors:  Henry N Luma; Servais A F B Eloumou; Cécile Okalla; Olivier Donfack-Sontsa; Ruth Koumitana; Agnes Malongue; Georges B Nko'Ayissi; Dominique N Noah
Journal:  J Clin Exp Hepatol       Date:  2017-05-25

5.  Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study.

Authors:  Cédric Hirzel; Gilles Wandeler; Marta Owczarek; Meri Gorgievski-Hrisoho; Jean-Francois Dufour; Nasser Semmo; Samuel Zürcher
Journal:  BMC Infect Dis       Date:  2015-10-30       Impact factor: 3.090

6.  Identification of pathogens for differential diagnosis of fever with jaundice in the Central African Republic: a retrospective assessment, 2008-2010.

Authors:  Christelle Luce Bobossi Gadia; Alexandre Manirakiza; Gaspard Tekpa; Xavier Konamna; Ulrich Vickos; Emmanuel Nakoune
Journal:  BMC Infect Dis       Date:  2017-11-29       Impact factor: 3.090

7.  Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review.

Authors:  Ottovon Bismark Dakurah; Cynthia Raissa Tchuem Tamandjou; Moleen Zunza; Wolfgang Preiser; Tongai Gibson Maponga
Journal:  BMC Cancer       Date:  2021-06-19       Impact factor: 4.430

8.  Molecular epidemiology of hepatitis D virus circulating in Southwestern Nigeria.

Authors:  Oluyinka Oladele Opaleye; Oluwatoyin Margaret Japhet; Olubusuyi Moses Adewumi; Ewean Chukwuma Omoruyi; Olusola Anuoluwapo Akanbi; Adeolu Sunday Oluremi; Bo Wang; Hoang van Tong; Thirumalaisamy P Velavan; C-Thomas Bock
Journal:  Virol J       Date:  2016-04-05       Impact factor: 4.099

Review 9.  Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Alexander J Stockdale; Mas Chaponda; Apostolos Beloukas; Richard Odame Phillips; Philippa C Matthews; Athanasios Papadimitropoulos; Simon King; Laura Bonnett; Anna Maria Geretti
Journal:  Lancet Glob Health       Date:  2017-10       Impact factor: 26.763

10.  Clade homogeneity and low rate of delta virus despite hyperendemicity of hepatitis B virus in Ethiopia.

Authors:  Yeshambel Belyhun; Uwe Gerd Liebert; Melanie Maier
Journal:  Virol J       Date:  2017-09-12       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.